E-DRUG Archives (by thread)

  • [e-drug] Ensuring ethical drug promotion--whose responsibility?, e-drug
  • [e-drug] WHO and ARV access (cont'd), maija . palander
  • [e-drug] WHO/AFRO report 2002 on essential medicines, e-drug
  • [e-drug] Ensuring ethical drug promotion--whose responsibility? (cont'd), pierre chirac
  • [e-drug] Dispensing Doctors Monitor article, Richard Laing
  • [e-drug] Ensuring ethical drug promotion (cont'd), Jude Nwokike
  • [e-drug] Worries about acceptance of MMR, Peter Copp
  • [e-drug] Dispensing Doctors Monitor article (cont'd), Bonface Fundafunda
  • [e-drug] MSF Documents on FTAA and TRIPS, Rachel Cohen
  • [e-drug] Africans Outdo Americans in Following AIDS Therapy, e-drug
  • [e-drug] DTCA and Canada 1, e-drug
  • [e-drug] DTCA and Canada 2, e-drug
  • [e-drug] DTCA and Canada 3, e-drug
  • [e-drug] Worries about acceptance of MMR (cont'd), Letitia Toms
  • [e-drug] Brazil and US ARV prices compared, James Love
  • [e-drug] WHO/AFRO: Medicines and hospitals in Africa, Leela McCullough
  • [e-drug] Revision on US and Brazilian ARV Price comparison, James Love
  • [e-drug] Two new documents on affordability and financing of ACTs, Hilbrand Haak
  • [e-drug] Unintended ARV treatment interruptions, Fionnuala Mc Cullagh
  • [e-drug] Unintended ARV treatment interruptions (cont'd), Murtada Sesay
  • [e-drug] FDA Anti-Counterfeit Drug Meeting, E-drug
  • [e-drug] Research in Rational Drug Use, G.B. Simpson
  • [e-drug] BMJ editorial on WTO/TRIPS Medicines, e-drug
  • [e-drug] Guidelines for drug disposal, Mona Hussein
  • [e-drug] Drug interactions service, Horst Herb
  • [e-drug] Guidelines for drug disposal (cont'd), James Russo
  • [e-drug] World's first nonprofit drug company launched, e-drug
  • [e-drug] World's first nonprofit drug company launched (cont'd), S. Srinivasan
  • [e-drug] Hydralazine deletion from 13th Model Essential Drug List, Norman Olson
  • [e-drug] Nifedipine deletion from 13th Model Essential Drug List, Norman Olson
  • [e-drug] Forbes article on OneWorld Health, Michael MacHarg
  • [e-drug] OneWorld Health and DNDI, Philippe Swennen
  • [e-drug] 118 essential medicines missing on the market: Survey, Azhar Hussain
  • [e-drug] WHO EDL Committee 2004 and proposed deletions, e-drug
  • [e-drug] Methyl xanthenes to be deleted from 13th Model EML 2003, Norman Olson
  • [e-drug] WHO EDL Committee 2004 and proposed deletions (cont'd), Ric Day
  • [e-drug] A bad week for drug companies?, e-drug
  • [e-drug] Drug pricing and affordability, Zaheer-Ud-din Baber
  • [e-drug] Research in Hospital Drug Use (cont'd), Richard Laing
  • [e-drug] Nifedipine deletion WHO Essential medicines List, Valeria Frighi
  • [e-drug] WHO Declaration of Global Health Emergency, Leela McCullough
  • [e-drug] UN session tackling African pandemic seeks to aid access, Leela McCullough
  • [e-drug] One World Health and DNDi (cont'd), Jaya Bannerji
  • [e-drug] WHO Model List of Essential Medicines, Hans Hogerzeil
  • [e-drug] HAI Fact Sheet Global Fund Requirements, HAI Africa
  • [e-drug] Promoting Rational Drug Use Course, Nairobi, Kenya (cont'd), John Chalker
  • [e-drug] Malaria: the terrorist's friend, e-drug
  • [e-drug] New FIP statements available online, Satu Tainio
  • [e-drug] UN session tackling African pandemic (cont'd), Valeria Frighi
  • [e-drug] 2nd Announcement - PRDU Course, Lahore, Pakistan, Azhar Hussain

  • Mail converted by MHonArc 2.6.8